ALLMedicine™ Movement Disorders Center

Jun 25th, 2022 - Essential tremor (ET) is one of the most common movement disorders, yet we do not have a complete understanding of its pathophysiology. From a phenomenology standpoint, ET is an isolated tremor syndrome of bilateral upper limb action tremor with o...

Jun 25th, 2022 - Ataxia is one of the most common pediatric movement disorders and can be caused by a large number of congenital and acquired diseases affecting the cerebellum or the vestibular or sensory system. It is mainly characterized by gait abnormalities, d...

Jun 25th, 2022 - Essential tremor is one of the most prevalent movement disorders. Propranolol and primidone are the first-line pharmacological therapies. They provide symptomatic control in less than 50% of patients. Topiramate, alprazolam, clonazepam, gabapentin...

Jun 24th, 2022 - Objective: The objective of this protocol is to provide standard of care DBS surgery and to collect prospective physiology data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), d...

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

Dec 30th, 2020 - Most patients with movement disorders have speech impairments resulting from sensorimotor abnormalities that affect phonatory, articulatory, and prosodic speech subsystems. There is widespread cross-discipline use of speech recordings for diagnost...

May 7th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Jan 15th, 2008 - Dementia and movement disorders.|2008|Dormont D,Seidenwurm DJ, , ,|classification,complications,diagnosis,standards,classification,complications,diagnosis,

Jun 24th, 2022 - Objective: The objective of this protocol is to provide standard of care DBS surgery and to collect prospective physiology data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), d...

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

Jun 24th, 2022 - Objective: The primary objective of this study is to perform phenotypic and genotypic characterizations of patients and family members with a known or suspected diagnosis of a movement disorder and screen for eligibility to participate in other mo...

Jun 24th, 2022 - Objectives: The study investigates the neurobiological correlates of conversion disorder (CD). The primary objectives are to investigate in CD patients: The role of emotional valence in an implicit emotional processing task (COMPLETE) The frequenc...

Jun 24th, 2022 - Deep brain stimulation (DBS) of different brain nuclei is evolving as an essential component of the treatment for multiple brain disorders. The subthalamic nucleus (STN) and globus pallidus have been used to treat advanced Parkinson's disease for ...

Jun 16th, 2022 - This transcript has been edited for clarity. Indu Subramanian, MD: It is so exciting to have you all join us again today. We're going to be talking about a really hot topic: functional neurologic disorders, and more specifically, functional moveme...

Jun 13th, 2022 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner, reporting on the American Epilepsy Society meeting. With me today is Dr Olga Taraschenko, director of the Comprehensive Epilepsy Program ...

May 19th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Hello, and welcome to Medscape. Today we'll be discussing highlights in movement disorders from the recent American Academy of Neurology (AAN) annual meeting. I have the great pleas...

May 18th, 2022 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm your host, Dr Andrew Wilner. Today, I am interviewing Dr Christopher Gibbons about his research presented at this year's American Academy of Neurology meet...

Mar 24th, 2022 - This transcript has been edited for clarity. Kathrin LaFaver, MD: Welcome to Medscape Neurology. I'm Dr Kathrin LaFaver, a neurologist and movement disorder specialist in Saratoga Springs, New York. I have the pleasure today of speaking with Dr In...